$2.61 -0.09 (-3.33%) Rigel Pharmaceuticals Inc - NASDAQ

Aug. 26, 2016 | 04:00 PM
Key Statistics
Last Trade: 2.61
Trade Time: Aug 26 04:00 PM Eastern Daylight Time
Change: -0.09 (-3.33%)
Prev Close: 2.70
Open: 2.72
Bid: 2.61
Ask: 2.62

Competitors

Ticker Name Volume % Change
EXAS Exact Sciences Corp 1.92M +0.73%
CYTR CytRx Corp 1.81M +1.83%
PDLI PDL Biopharma Inc 1.69M +4.38%
THLD Threshold Pharmaceuticals 978.48K +0.57%
SGMO Sangamo Biosciences Inc 854.83K +2.39%

RIGL Stock Analysis

  1. No results found.

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST